The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent. [electronic resource]
Producer: 20130801Description: 423-30 p. digitalISSN:- 1432-1041
- Administration, Oral
- Adult
- Analysis of Variance
- Area Under Curve
- Biotransformation
- Cross-Over Studies
- Double-Blind Method
- Female
- Glucuronosyltransferase -- genetics
- Half-Life
- Heterozygote
- Homozygote
- Humans
- Hypoglycemic Agents -- administration & dosage
- Male
- Metabolic Clearance Rate
- Middle Aged
- Pharmacogenetics
- Phenotype
- Polymorphism, Genetic
- Propionates -- administration & dosage
- Thiazoles -- administration & dosage
- United Kingdom
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.